MIRATA BIOPHARMA
MIRATA BIOPHARMA
Social Links:
Industry:
Biopharma Biotechnology Health Care
Founded:
2017-01-01
Address:
Natick, Massachusetts, United States
Country:
United States
Website Url:
http://www.miratabiopharma.com
Total Employee:
1+
Status:
Active
Contact:
781-761-0123
Technology used in webpage:
Domain Not Resolving
Similar Organizations
C-Beyond Health Inc.dba Medimorphic
Biotechnology, Bio-Pharmacutical, Health Care Product Development
Giiant Pharma
Giiant Pharma is a preclinical-stage biotech company.
SA Biotech
SA Biotech is a Healthcare company.
Official Site Inspections
http://www.miratabiopharma.com
Unable to get host informations!!!
More informations about "Mirata BioPharma"
Mirata BioPharma - Products, Competitors, Financials, Employees ...
Its initial focus is to develop biopharmaceutical compounds licensed from the research development foundation, a nonprofit supporting organization of the Clayton Foundation for …See details»
Mirata BioPharma Becomes Resident Company at Johnson
Mar 28, 2018 · HOUSTON-- ( BUSINESS WIRE )--Mirata BioPharma, LLC, an immuno-oncology company, announced today that it is now a Resident Company at Johnson & Johnson …See details»
Mirata BioPharma - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Mirata BioPharma. Use the PitchBook Platform to explore the full profile.See details»
Mirata BioPharma - Overview, News & Similar companies
View Mirata BioPharma (www.miratabiopharma.com) location in Texas, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Mirata BioPharma - Crunchbase Company Profile
Mirata BioPharma is located in Natick, Massachusetts, United States. Who are Mirata BioPharma's competitors? Alternatives and possible competitors to …See details»
Mirata BioPharma Company Profile - Office Locations ... - Craft
Mirata BioPharma is a company specializing in cancer therapies. It aims to develop Targeted Granzyme B Immunotherapy (TGI) for oncology patients.See details»
Mirata BioPharma - VentureRadar
Website: http://www.miratabiopharma.com/ Associated sectors: Oncology; Biologics; Website archive shows the site http://www.miratabiopharma.com/ was first archived on 2018. Similar …See details»
Mirata BioPharma, LLC Receives Top Honors at the 6th
Dec 13, 2017 · Mirata Biopharma LLC is an immuno-oncology company that is developing a breakthrough targeted recombinant fusion protein platform that utilizes the body natural …See details»
Mirata BioPharma Becomes Resident Company at Johnson
Mar 29, 2018 · Recognized as one of the Rice Alliance’s 10 Most Promising Life Science Companies in 2017, Mirata BioPharma is a pre-clinical stage immuno-oncology company that …See details»
MIRATA BioPharma, LLC Company Profile - Dun & Bradstreet
MIRATA BioPharma, LLC Company Profile | Spring, TX | Competitors, Financials & Contacts - Dun & Bradstreet Find company research, competitor information, contact details & financial …See details»
Mirata BioPharma - Company Profile - Tracxn
Oct 25, 2024 · Mirata BioPharma - Developing immuno-oncology drugs based on targeted granzyme B immunotherapy. This company is not active anymore. Raised funding over 1 …See details»
Mirata BioPharma - VentureRadar
As the first biopharmaceutical company to build a platform bringing innovative therapies from China to the world, we adopt a holistic approach to drug development, combining exceptional …See details»
MIRATA BioPharma - LinkedIn
Nov 10, 2017 · Mirta BioPharma was recognized as one of the Rice Alliance 10 Most Promising Life Science Companies at the 2017 Texas Life Science Forum hosted by the Rice Alliance for …See details»
Research programme: immuno-oncology therapeutics - Mirata …
Mirata Biopharma is developing oncology therapeutics based on the Targeted Granzyme B Immunotherapy (TGI) platform, for the treatment of cancers including,See details»
MRT-301 - Drug Targets, Indications, Patents - Synapse - Patsnap
MRT-301: a Chondroitin sulfate proteoglycans modulators Drug, Initially developed by Clayton Foundation for Research, Now, its global highest R&D status is Discovery, Mechanism: …See details»
MRT-101 (MIRATA BioPharma): Targeted Granzyme B Immuno
Apr 24, 2018 · GrB-Fc-IT4 (MRT-101) contains a humanized scFv binding domain targeting the cell surface receptor Fn14, an antigen highly expressed in a variety of solid tumors, and the …See details»
Mirata BioPharma, LLC Receives Top Honors at the 6th Annual
Dec 14, 2017 · HOUSTON--(BUSINESS WIRE)-- Mirata BioPharma, LLC was recognized as one of the Rice Alliance 10 Most Promising Life Science Companies at the 2017 Texas Life …See details»
Mirata Biopharma LLC: 药物管线_专利_临床试验_投融营收_最新药 …
了解Mirata Biopharma LLC公司的药物管线，治疗领域，技术平台，以及它的，疾病领域:肿瘤，技术平台:单克隆抗体，单链Fv片段抗体，融合蛋白，药物:MRT-101，MRT-201，MRT-301。See details»
101 Top BioPharma Startups & Companies (Canada)
Canada is home to a range of established and new BioPharma companies. With a strong foundation & a maturing regulatory space Canada offers a wide range of opportunities for …See details»
I-Mab | Pioneering the Next Generation of Immuno-Oncology
Oct 31, 2024 · Third Venture Biopharma and Tasgen merged to form I-Mab, raising $120 million in Series B Financing. I-Mab successfully raised $227 million in Series C Financing. I-Mab was …See details»